BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Free Report) was the recipient of a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 800 shares, a decline of 38.5% from the August 15th total of 1,300 shares. Based on an average daily volume of 59,200 shares, the short-interest ratio is presently 0.0 days.
BetterLife Pharma Price Performance
BETRF stock opened at $0.10 on Monday. BetterLife Pharma has a 1-year low of $0.03 and a 1-year high of $0.15. The firm has a fifty day moving average price of $0.11 and a two-hundred day moving average price of $0.09. The firm has a market cap of $12.30 million, a price-to-earnings ratio of -3.17 and a beta of 1.23.
BetterLife Pharma (OTCMKTS:BETRF – Get Free Report) last released its earnings results on Thursday, June 27th. The company reported ($0.01) earnings per share for the quarter.
About BetterLife Pharma
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.
Featured Stories
- Five stocks we like better than BetterLife Pharma
- How to Evaluate a Stock Before Buying
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- How to Plot Fibonacci Price Inflection Levels
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- 5 Top Rated Dividend Stocks to Consider
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
